Clinical Trial Update: CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating CR845 for safety and effectiveness in hemodialysis patients with moderate-to-severe pruritus has completed; results were posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pruritus in Chronic Kidney Disease
• Uremic Pruritus

Drugs mentioned

• CR845 (difelikefalin)

Snippet

Sponsor: Cara Therapeutics, Inc. | Conditions: Uremic Pruritus | Phase 3 | Status: COMPLETED | Results posted: 2021-10-15